Albert Jang
Impact in
-
- Prostate Cancer Treatment and Research
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
Papers in
-
- Prostate Cancer Treatment and Research 13
- Renal cell carcinoma treatment 9
- Ferroptosis and cancer prognosis 3
- Oncology 12
- Cancer Immunotherapy and Biomarkers 5
- Co-authors
- Oliver Sartor (15 shared papers)A. Tuba Kendi (2 shared papers)Pedro C. Barata (24 shared papers)Jin Wang (2 shared papers)Min Chen (2 shared papers)Þorvarður R. Hálfdánarson (1 shared paper)Geoffrey B. Johnson (1 shared paper)Srikanth Kodali (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)The Oncologist (3 papers)Cancers (3 papers)Blood (1 paper)JCO Precision Oncology (1 paper)
- Partner nations
- United StatesItalyBrazil
In The Last Decade
Albert Jang
41 papers receiving 507 citations
Peers
Comparison fields: 5 of 86
- Pulmonary and Respiratory Medicine 135
- Radiology, Nuclear Medicine and Imaging 91
- Oncology 94
- Infectious Diseases 55
- Epidemiology 92
Countries citing papers authored by Albert Jang
This map shows the geographic impact of Albert Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Jang more than expected).
Fields of papers citing papers by Albert Jang
This network shows the impact of papers produced by Albert Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Jang. The network helps show where Albert Jang may publish in the future.
Co-authors
The 25 scholars most cited alongside Albert Jang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 78 | |
| 2 | 2023 | 62 | |
| 3 | 2023 | 61 | |
| 4 | 2015 | 58 | |
| 5 | 2020 | 32 | |
| 6 | 2020 | 31 | |
| 7 | 2019 | 16 | |
| 8 | 2020 | 16 | |
| 9 | 2023 | 15 | |
| 10 | 2020 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2023 | 13 | |
| 13 | 2023 | 13 | |
| 14 | 2021 | 11 | |
| 15 | 2018 | 8 | |
| 16 | 2024 | 6 | |
| 17 | 2022 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2020 | 5 |
About Albert Jang
Albert Jang is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 47 papers that have together received 514 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (13 papers), Cancer Genomics and Diagnostics (11 papers), Renal cell carcinoma treatment (9 papers), Bladder and Urothelial Cancer Treatments (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ferroptosis and cancer prognosis (3 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (135 citations), Radiology, Nuclear Medicine and Imaging (91 citations), Oncology (94 citations), Infectious Diseases (55 citations) and Epidemiology (92 citations). Albert Jang has collaborated with scholars based in United States, Italy and Brazil. Frequent co-authors include Oliver Sartor, A. Tuba Kendi, Pedro C. Barata, Jin Wang, Min Chen, Þorvarður R. Hálfdánarson, Geoffrey B. Johnson, Srikanth Kodali, John Xie and Jordan J. Karlitz. Their work appears in journals such as Journal of Clinical Oncology, The Oncologist, Cancers, Blood and JCO Precision Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.